Recent Security Class Actions

RECKITT BENCKISR GP S/ADR (US TRADING VENUE: RBGLY)

Company Name:RECKITT BENCKISR GP S/ADR
Stock Symbol:US TRADING VENUE: RBGLY
Class Period Start:07/28/2014
Class Period End (inclusive):04/09/2019
Filing Deadline:09/13/2019

According to the Complaint, Reckitt Benckiser Group plc is a consumer goods and health conglomerate.

The Complaint alleges that before and during the Class Period, Reckitt and its most senior executives perpetrated a scheme, which generated over $3 billion in proceeds, to facilitate opiate abuse among U.S. consumers and mislead investors and the public regarding the health and safety risks of Reckitt's new key opiate product, Suboxone Film. Specifically, the Complaint alleges that in order to maintain and grow profits, senior executives at Reckitt devised a plan to switch prescribers from Suboxone Tablets to the Company's new proprietary treatment, Suboxone Film and that as a result of Defendants' false and misleading statements and/or omissions regarding the scheme to inflate sales of Suboxone Film during the Class Period, Reckitt ADSs traded at artificially inflated prices.